Health Canada has authorized bioLytical’s INSTI Multiplex HIV-1/HIV-2/Syphilis Antibody Test (INSTI multiplex test) for clinical use. In Canada, this is the first approved rapid point-of-care (POC) test for both HIV and syphilis and the first approved rapid POC syphilis test of any kind. The INSTI multiplex test is a single screening test that detects both HIV and syphilis antibodies using a single blood sample. The test requires a few drops of blood from a finger prick and produces accurate results within minutes.
A person can get hepatitis C again if they are exposed to the virus after they are cured with treatment or have cleared the virus on their own. This is called reinfection. Reinfections follow the same principles as a primary (first) hepatitis C infection — they are transmitted through blood-to-blood contact (e.g., sharing equipment for injecting drugs) and are cured through treatment with direct-acting antivirals (DAAs). The cure rate for treatment of hepatitis C reinfections is as high as it is for treatment of a primary (first) hepatitis C infection.